Status:
COMPLETED
Evaluation of LB in THA
Lead Sponsor:
OSF Healthcare System
Collaborating Sponsors:
University of Illinois College of Medicine at Peoria
Conditions:
Hip Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to compare the effectiveness of liposomal bupivacaine (LB) versus standard of practice local injection containing plain bupivacaine.
Detailed Description
Investigation of liposomal bupivacaine to determine if this drug is a valid alternative to standard of care local anesthesia based on evaluation in total hip arthroplasty This is a retrospective cohor...
Eligibility Criteria
Inclusion
- Males or females over the age of 18
- have undergone a THA surgery during the period of interest January 2013 to July 2016).
Exclusion
- excluded from the study based on the following criteria:
- Concurrent, painful, physical condition or concurrent surgery that may require analgesic treatment in the postoperative period for pain that is not strictly related to the surgical treatment;
- Uncontrolled anxiety, schizophrenia, or other psychiatric disorder; and
- Significant renal or hepatic insufficiency.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2016
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT03341104
Start Date
January 1 2013
End Date
July 30 2016
Last Update
November 14 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.